Kopran Limited operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kopran Limited with three other
companies in this sector in India:
RPG Life Sciences Limited
sales of 3.30 billion Indian Rupees [US$46.26 million]
Albert David Limited
(3.17 billion Indian Rupees [US$44.40 million]
Advanced Enzyme Technologies Ltd
(4.20 billion Indian Rupees [US$58.78 million]
of which 100%
was Manufacturing and sale of Enzymes).
During the year ended March of 2019, sales at
Kopran Limited were 3.58 billion Indian Rupees (US$50.14 million).
increase of 13.7%
versus 2018, when the company's sales were 3.15 billion Indian Rupees.
This was the third consecutive year of growth at Kopran Limited.